Meta-analysis of Telomere Length in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Alzheimer's disease (AD) is a common and severe neurodegenerative disorder. Human telomeres are fundamental for the maintenance of genomic stability and play prominent roles in both cellular senescence and organismal aging. Regulation of telomere length (TL) is the result of the complex interplay between environmental and genetic factors. Alterations in TL are increasingly being studied as a possible risk factor for AD, and published studies on TL in AD show discrepant results, highlighting the need for a meta-analysis. METHODS: In the current study, we carried out a meta-analysis of published studies of TL in AD patients and healthy controls. PubMed, Web of Science and Google Scholar databases (from inception to September 2015) were used to identify relevant articles reporting TL in humans with AD, from which we retrieved data such as sample size, experimental methods, and mean TL for cases and controls. A random-effects model was used for meta-analytical procedures. RESULTS: The meta-analysis included 13 primary studies and demonstrated a significant difference in TL between 860 AD patients and 2,022 controls, with a standardized mean difference of -0.984 (confidence interval: -1.433 to -0.535; p value: <.001). CONCLUSIONS: Our results show a consistent evidence of shorter telomeres in AD patients and highlight the importance of the analysis of epigenomic markers associated with neurodegeneration and with the risk for common and severe neurological diseases, such as AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In AD, PD, and HD, aging has also been associated with increased telomere attrition [61,62,63].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [61]
In the citing paper
“Finally, an association between telomere shortening and AD has been suggested [246,247,248].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [248]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“We followed the recommendations of the PRISMA statement (9) for reporting of meta-analyses (Supplementary Figure S1).”
MethodPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“Genomic studies have identified several causal genes for hereditary subtypes of AD (such as APP, PSEN1, and PSEN2) and susceptibility genes for its multifactorial forms (such as APOE, CLU, and CR1) (1,2).”
BackgroundMeta-Analyst: software for meta-analysis of binary, continuous and diagnostic data
Wallace, B. C., Schmid, C. H., Lau, J., & Trikalinos, T. A. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-80 · Cited by 659
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473 · cited 3×
“Several theories about the etiology and pathophysiology of AD have been developed, which highlight the importance of mechanisms involved in the response to cell-intrinsic and cell-extrinsic stresses and of alterations in neural plasticity (1,3).”
BackgroundTelomere shortening in T cells correlates with Alzheimer's disease status
Panossian, L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00043-x · Cited by 411 · cited 3×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
BackgroundResultLindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.007 · Cited by 285 · cited 3×
“For instance, it has been suggested that telomere maintenance mechanisms play an important role in the response and plasticity of postmitotic neurons to oxidative and genomic stress (4,5).”
BackgroundThomas, P., O’ Callaghan, N. J., & Fenech, M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.004 · Cited by 250 · cited 1×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
ResultChen, W., Kimura, M., Kim, S., Cao, X., Srinivasan, S. R., Berenson, G. S., Kark, J. D., & Aviv, A. (2011) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq223 · Cited by 213 · cited 1×
“Future studies using high-throughput approaches, such as nextgeneration sequencing, could identify novel genetic and epigenetic factors (39) that influence TL in AD patients and in its presymptomatic stages (40).”
BackgroundSystematic Reviews of Genetic Association Studies
Sagoo, G. S., Little, J., & Higgins, J. P. T. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000028 · Cited by 182
Association of Shorter Leukocyte Telomere Repeat Length With Dementia and Mortality
Honig, L. S., Kang, M. S., Schupf, N., Lee, J. H., & Mayeux, R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1541 · Cited by 179 · cited 1×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
ResultHuman telomere biology: pitfalls of moving from the laboratory to epidemiology
Aviv, A., Valdes, A. M., & Spector, T. D. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl169 · Cited by 172 · cited 1×
“Several studies used DNA extracted from leukocytes, taking into account its broad and easy availability for large samples of living patients (25).”
BackgroundTelomere shortening in neurological disorders: an abundance of unanswered questions
Eitan, E., Hutchison, E. R., & Mattson, M. P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.010 · Cited by 158 · cited 5×
“Although TL has been evaluated as a possible biomarker for AD in several publications, no meta-analysis has been conducted so far to assess the relative importance of such results (6,24).”
BackgroundInfluentialThe Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro
Spilsbury, A., Miwa, S., Attems, J., & Saretzki, G. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2925-14.2015 · Cited by 140
Telomere length is age-dependent and reduced in monocytes of Alzheimer patients
Hochstrasser, T., Marksteiner, J., & Humpel, C. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.012 · Cited by 132 · cited 1×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
ResultTelomere Shortening and Alzheimer’s Disease
Cai, Z., Yan, L., & Ratka, A. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8207-9 · Cited by 128 · cited 1×
“Although TL has been evaluated as a possible biomarker for AD in several publications, no meta-analysis has been conducted so far to assess the relative importance of such results (6,24).”
BackgroundComparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease
Lukens, J. N., Van Deerlin, V., Clark, C. M., Xie, S. X., & Johnson, F. B. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.05.666 · Cited by 128
Effects of physical activity in telomere length: Systematic review and meta-analysis
Mundstock, E., Zatti, H., Louzada, F. M., Oliveira, S. G., Guma, F. T. C. R., Paris, M. M., Rueda, A. M. B., Machado, D. G., Stein, R. T., Jones, M. H., et al. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.02.004 · Cited by 117 · cited 1×
“Finally, emerging evidence suggests that perceived stress and lower physical activity, known risk factors for AD, are associated with shorter telomeres (33,34).”
BackgroundDNA damage responses in neural cells: Focus on the telomere
Zhang, P., Dilley, C. M., & Mattson, M. P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.052 · Cited by 115 · cited 2×
“For instance, it has been suggested that telomere maintenance mechanisms play an important role in the response and plasticity of postmitotic neurons to oxidative and genomic stress (4,5).”
BackgroundTelomere Length Shortening and Alzheimer Disease—A Mendelian Randomization Study
Zhan, Y., Song, C., Karlsson, R., Tillander, A., Reynolds, C. A., Pedersen, N. L., & Hägg, S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1513 · Cited by 111 · cited 1×
“Future studies using high-throughput approaches, such as nextgeneration sequencing, could identify novel genetic and epigenetic factors (39) that influence TL in AD patients and in its presymptomatic stages (40).”
BackgroundTelomere shortening reduces Alzheimer’s disease amyloid pathology in mice
Rolyan, H., Scheffold, A., Heinrich, A., Begus-Nahrmann, Y., Langkopf, B. H., Hölter, S. M., Vogt-Weisenhorn, D. M., Liss, B., Wurst, W., Lie, D. C., et al. (2011) · Brain · doi:10.1093/brain/awr133 · Cited by 106 · cited 2×
“It has been shown that the third generation of knockout mice for the telomerase RNA component TERC (G3Terc−/−, which display short telomeres) have reduced neurogenesis in the dentate gyrus, in addition to neuronal loss in hippocampus and frontal cortex and short-term memory dysfunction (29).”
BackgroundHippocampal telomerase is involved in the modulation of depressive behaviors
Zhou, Q.-G., Hu, Y., Wu, D.-L., Zhu, L.-J., Chen, C., Jin, X., Luo, C.-X., Wu, H.-Y., Zhang, J., & Zhu, D.-Y. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0805-11.2011 · Cited by 105 · cited 1×
“There is also evidence showing that newly generated neurons and mature neurons have low telomerase levels and are more susceptible to the effects of DNA damage (30), that the antidepressant-effect of telomerase overexpression is possibly associated to adult neurogenesis mechanisms (31), and that lithium normalizes tel…”
BackgroundKing, K. S., Kozlitina, J., Rosenberg, R. N., Peshock, R. M., McColl, R. W., & Garcia, C. K. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1926 · Cited by 95 · cited 1×
“King and coworkers (35) identified a significant correlation between leukocyte TL and volume of total brain and specific regions, such as hippocampus.”
BackgroundThe Relationship Between Perceived Stress and Telomere Length: A Meta‐analysis
Schutte, N. S., & Malouff, J. M. (2016) · Stress and Health · doi:10.1002/smi.2607 · Cited by 88 · cited 1×
“Finally, emerging evidence suggests that perceived stress and lower physical activity, known risk factors for AD, are associated with shorter telomeres (33,34).”
BackgroundSynaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
Forero, D. A., Casadesus, G., Perry, G., & Arboleda, H. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00439.x · Cited by 85 · cited 1×
“Several theories about the etiology and pathophysiology of AD have been developed, which highlight the importance of mechanisms involved in the response to cell-intrinsic and cell-extrinsic stresses and of alterations in neural plasticity (1,3).”
BackgroundSelf-citationElbers, C. C., Garcia, M. E., Kimura, M., Cummings, S. R., Nalls, M. A., Newman, A. B., Park, V., Sanders, J. L., Tranah, G. J., Tishkoff, S. A., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt121 · Cited by 79 · cited 1×
“It is possible that the interstudy variability in the TL data shown in Table 1 is given by the use of different approaches for normalization of quantitative polymerase chain reaction results (26).”
MethodTelomerase Dysregulation in the Hippocampus of a Rat Model of Depression: Normalization by Lithium
Wei, Y. B., Backlund, L., Wegener, G., Mathe, A. A., & Lavebratt, C. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv002 · Cited by 79 · cited 1×
“There is also evidence showing that newly generated neurons and mature neurons have low telomerase levels and are more susceptible to the effects of DNA damage (30), that the antidepressant-effect of telomerase overexpression is possibly associated to adult neurogenesis mechanisms (31), and that lithium normalizes tel…”
BackgroundCheng, A., Shin-ya, K., Wan, R., Tang, S.-C., Miura, T., Tang, H., Khatri, R., Gleichman, M., Ouyang, X., Liu, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0590-07.2007 · Cited by 75 · cited 1×
“There is also evidence showing that newly generated neurons and mature neurons have low telomerase levels and are more susceptible to the effects of DNA damage (30), that the antidepressant-effect of telomerase overexpression is possibly associated to adult neurogenesis mechanisms (31), and that lithium normalizes tel…”
BackgroundFranco, S., Blasco, M. A., Siedlak, S. L., Harris, P. L. R., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2006.03.001 · Cited by 74 · cited 1×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
ResultSelf-citationMovérare‐Skrtic, S., Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J.-O., Zetterberg, H., Blennow, K., & Svensson, J. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.12.005 · Cited by 61 · cited 1×
“It was not possible to include two additional studies, which did not provide TL data (22,23) (Supplementary Figure S1).”
BackgroundIs bipolar disorder associated with accelerating aging? A meta-analysis of telomere length studies
Colpo, G. D., Leffa, D. D., Köhler, C. A., Kapczinski, F. P., Quevedo, J., & Carvalho, A. F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.034 · Cited by 59 · cited 1×
“Quality assessment of included studies was carried out with a modified version of the Newcastle-Ottawa Quality Assessment Scale, as proposed by Colpo and coworkers (10) for meta-analyses of case–control studies of TL.”
MethodGuan, J.-Z., Guan, W.-P., Maeda, T., & Makino, N. (2012) · Gerontology · doi:10.1159/000327821 · Cited by 57
Wikgren, M., Karlsson, T., Nilbrink, T., Nordfjäll, K., Hultdin, J., Sleegers, K., Broeckhoven, C. V., Nyberg, L. H., Roos, G., Nilsson, L., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.004 · Cited by 55
Zekry, D., Herrmann, F. R., Irminger-Finger, I., Graf, C., Genet, C., Vitale, A.-M., Michel, J.-P., Gold, G., & Krause, K.-H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.07.019 · Cited by 54 · cited 1×
“It was not possible to include two additional studies, which did not provide TL data (22,23) (Supplementary Figure S1).”
BackgroundReduced telomere length in neurodegenerative disorders may suggest shared biology
Kota, L. N., Bharath, S., Purushottam, M., Moily, N. S., Sivakumar, P. T., Varghese, M., Pal, P. K., & Jain, S. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13100240 · Cited by 53 · cited 2×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
BackgroundResultAssociation Between ApoE Phenotypes and Telomere Erosion in Alzheimer’s Disease
Takata, Y., Kikukawa, M., Hanyu, H., Koyama, S., Shimizu, S., Umahara, T., Sakurai, H., Iwamoto, T., Ohyashiki, K., & Ohyashiki, J. H. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr185 · Cited by 52
Mathur, S., Głogowska, A., McAvoy, E., Righolt, C. H., Rutherford, J., Willing, C., Banik, U., Ruthirakuhan, M. T., Mai, S., & Garcia, A. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130866 · Cited by 40 · cited 1×
“984) is consistent with results from individual studies that reported shorter telomeres in AD patients (7,8,14,17,18,20,21).”
ResultWikgren, M., Karlsson, T., Lind, J., Nilbrink, T., Hultdin, J., Sleegers, K., Van Broeckhoven, C., Roos, G., Nilsson, L.-G., Nyberg, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034292 · Cited by 38
Medical genetics and epigenetics of telomerase
Koziel, J. E., Fox, M. J., Steding, C. E., Sprouse, A. A., & Herbert, B.-S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01276.x · Cited by 36 · cited 1×
“A number of epigenetic factors, such as modifications of DNA methylation in the promoter region of the catalytic subunit of the telomerase enzyme and several noncoding RNAs, are known to have an effect on telomere dynamics (38) and could be related to shorter telomeres in AD patients.”
BackgroundLeukocyte Telomere Length in Alzheimer’s Disease Patients with a Different Rate of Progression
Tedone, E., Arosio, B., Colombo, F., Ferri, E., Asselineau, D., Piette, F., Gussago, C., Belmin, J., Pariel, S., Benlhassan, K., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142808 · Cited by 36
Neuropsychiatric genetics in developing countries: Current challenges
Forero, D. A., Vélez-van-Meerbeke, A., Deshpande, S. N., Nicolini, H., & Perry, G. (2014) · World Journal of Psychiatry · doi:10.5498/wjp.v4.i4.69 · Cited by 31 · cited 1×
“We did not find studies on TL and AD in African, South Eastern Asian, or Latin American countries, populations that have a large burden of neurodegenerative disorders and particular genetic and environmental features (27).”
ResultSelf-citation
Cited by
Jylhävä, J., Pedersen, N. L., & Hägg, S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.046 · Cited by 1,240
“Likewise, in ADpatients, telomere lengths have been shown to be shorter, both in observational (Forero et al., 2016a) and causal Mendelian Randomization (Zhan et al., 2015) studies.”
BackgroundCellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514
“Interestingly, in the context of neurodegenerative diseases, leukocytes of AD patients exhibit shorter telomeres (44), whereas those of PD patients do not (45).”
Vaiserman, A., & Krasnienkov, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.630186 · Cited by 454
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Brain age and other bodily ‘ages’: implications for neuropsychiatry
Cole, J. H., Marioni, R. E., Harris, S. E., & Deary, I. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0098-1 · Cited by 440
Metadata
- Authors
- Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G.
- Affiliations
- Universidad Antonio Nariño (CO)
- Pontificia Universidad Javeriana (CO)
- The University of Texas at San Antonio (US)
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-18
- Volume
- 71
- Issue
- 8
- Pages
- 1069-1073
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- PMC
- PMC4945891
- OpenAlex
- W2336483756
- Cited by
- 229
- References
- 43
- Citations by year
- 2026: 4 · 2025: 23 · 2024: 27 · 2023: 18 · 2022: 23 · 2021: 31 · 2020: 35 · 2019: 28 · 2018: 20 · 2017: 13 · 2016: 5
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journals of Gerontology Series A (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute on Drug Abuse (T32DA021129)
- National Institutes of Health (G12-MD007591)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- telomere length, Alzheimer's disease, cellular senescence, aging, neurodegeneration, telomere shortening, dementia risk
- MeSH terms
- Aging, Alzheimer Disease, Humans, Risk Factors, Telomere, Evidence-Based Medicine, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.